Membrane pore size impacts performance of a xenogeneic bioartificial liver

Takakazu Matsushita, Bruce Amiot, Joseph Hardin, Jeffrey L. Platt, Scott Nyberg

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Background. We have developed a novel bioartificial liver (BAL) composed of porcine hepatocyte spheroids in a reservoir design. A semipermeable membrane is used to protect the spheroids from immune-mediated damage. This study was designed to assess the influence of membrane pore size on performance of the spheroid reservoir BAL. Methods. Eight healthy dogs were studied during primary and secondary exposures to the spheroid reservoir BAL using membranes with small (10 nm) or large (200 nm) pores. BAL performance was assessed by multiple functional assays. Spheroids were examined microscopically before and after all BAL treatments. Titers of xenoreactive antibody were monitored until elective death of animals on day 42. Results. Viability and functional performance of spheroids were significantly greater after all BAL treatments that used membranes with 10-nm versus 200-nm pores. Reduced performance in the 200 nm group was associated with 7.7-fold and 78.0-fold rise in xenoreactive antibody titers after first and second treatments, respectively. Dogs in the 10 nm group remained hemodynamically stable during all BAL treatments, whereas those in the 200 nm group experienced acute hypotension (P<0.001) during second BAL exposures. Microscopic examination of spheroids after BAL treatments indicated that deposition of canine proteins, including complement, was associated with reductions in both viability and functional performance of the BAL. Conclusions. The elicited immune response of healthy dogs to a xenogeneic BAL was blocked and BAL performance significantly improved by reducing the permeability of the BAL membrane.

Original languageEnglish (US)
Pages (from-to)1299-1305
Number of pages7
JournalTransplantation
Volume76
Issue number9
DOIs
StatePublished - Nov 15 2003

Fingerprint

Artificial Liver
Membranes
Dogs
Antibodies
Hypotension

ASJC Scopus subject areas

  • Transplantation
  • Immunology

Cite this

Membrane pore size impacts performance of a xenogeneic bioartificial liver. / Matsushita, Takakazu; Amiot, Bruce; Hardin, Joseph; Platt, Jeffrey L.; Nyberg, Scott.

In: Transplantation, Vol. 76, No. 9, 15.11.2003, p. 1299-1305.

Research output: Contribution to journalArticle

Matsushita, Takakazu ; Amiot, Bruce ; Hardin, Joseph ; Platt, Jeffrey L. ; Nyberg, Scott. / Membrane pore size impacts performance of a xenogeneic bioartificial liver. In: Transplantation. 2003 ; Vol. 76, No. 9. pp. 1299-1305.
@article{e82e4c5373444c69a7dfac982643c236,
title = "Membrane pore size impacts performance of a xenogeneic bioartificial liver",
abstract = "Background. We have developed a novel bioartificial liver (BAL) composed of porcine hepatocyte spheroids in a reservoir design. A semipermeable membrane is used to protect the spheroids from immune-mediated damage. This study was designed to assess the influence of membrane pore size on performance of the spheroid reservoir BAL. Methods. Eight healthy dogs were studied during primary and secondary exposures to the spheroid reservoir BAL using membranes with small (10 nm) or large (200 nm) pores. BAL performance was assessed by multiple functional assays. Spheroids were examined microscopically before and after all BAL treatments. Titers of xenoreactive antibody were monitored until elective death of animals on day 42. Results. Viability and functional performance of spheroids were significantly greater after all BAL treatments that used membranes with 10-nm versus 200-nm pores. Reduced performance in the 200 nm group was associated with 7.7-fold and 78.0-fold rise in xenoreactive antibody titers after first and second treatments, respectively. Dogs in the 10 nm group remained hemodynamically stable during all BAL treatments, whereas those in the 200 nm group experienced acute hypotension (P<0.001) during second BAL exposures. Microscopic examination of spheroids after BAL treatments indicated that deposition of canine proteins, including complement, was associated with reductions in both viability and functional performance of the BAL. Conclusions. The elicited immune response of healthy dogs to a xenogeneic BAL was blocked and BAL performance significantly improved by reducing the permeability of the BAL membrane.",
author = "Takakazu Matsushita and Bruce Amiot and Joseph Hardin and Platt, {Jeffrey L.} and Scott Nyberg",
year = "2003",
month = "11",
day = "15",
doi = "10.1097/01.TP.0000080067.79190.3C",
language = "English (US)",
volume = "76",
pages = "1299--1305",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

TY - JOUR

T1 - Membrane pore size impacts performance of a xenogeneic bioartificial liver

AU - Matsushita, Takakazu

AU - Amiot, Bruce

AU - Hardin, Joseph

AU - Platt, Jeffrey L.

AU - Nyberg, Scott

PY - 2003/11/15

Y1 - 2003/11/15

N2 - Background. We have developed a novel bioartificial liver (BAL) composed of porcine hepatocyte spheroids in a reservoir design. A semipermeable membrane is used to protect the spheroids from immune-mediated damage. This study was designed to assess the influence of membrane pore size on performance of the spheroid reservoir BAL. Methods. Eight healthy dogs were studied during primary and secondary exposures to the spheroid reservoir BAL using membranes with small (10 nm) or large (200 nm) pores. BAL performance was assessed by multiple functional assays. Spheroids were examined microscopically before and after all BAL treatments. Titers of xenoreactive antibody were monitored until elective death of animals on day 42. Results. Viability and functional performance of spheroids were significantly greater after all BAL treatments that used membranes with 10-nm versus 200-nm pores. Reduced performance in the 200 nm group was associated with 7.7-fold and 78.0-fold rise in xenoreactive antibody titers after first and second treatments, respectively. Dogs in the 10 nm group remained hemodynamically stable during all BAL treatments, whereas those in the 200 nm group experienced acute hypotension (P<0.001) during second BAL exposures. Microscopic examination of spheroids after BAL treatments indicated that deposition of canine proteins, including complement, was associated with reductions in both viability and functional performance of the BAL. Conclusions. The elicited immune response of healthy dogs to a xenogeneic BAL was blocked and BAL performance significantly improved by reducing the permeability of the BAL membrane.

AB - Background. We have developed a novel bioartificial liver (BAL) composed of porcine hepatocyte spheroids in a reservoir design. A semipermeable membrane is used to protect the spheroids from immune-mediated damage. This study was designed to assess the influence of membrane pore size on performance of the spheroid reservoir BAL. Methods. Eight healthy dogs were studied during primary and secondary exposures to the spheroid reservoir BAL using membranes with small (10 nm) or large (200 nm) pores. BAL performance was assessed by multiple functional assays. Spheroids were examined microscopically before and after all BAL treatments. Titers of xenoreactive antibody were monitored until elective death of animals on day 42. Results. Viability and functional performance of spheroids were significantly greater after all BAL treatments that used membranes with 10-nm versus 200-nm pores. Reduced performance in the 200 nm group was associated with 7.7-fold and 78.0-fold rise in xenoreactive antibody titers after first and second treatments, respectively. Dogs in the 10 nm group remained hemodynamically stable during all BAL treatments, whereas those in the 200 nm group experienced acute hypotension (P<0.001) during second BAL exposures. Microscopic examination of spheroids after BAL treatments indicated that deposition of canine proteins, including complement, was associated with reductions in both viability and functional performance of the BAL. Conclusions. The elicited immune response of healthy dogs to a xenogeneic BAL was blocked and BAL performance significantly improved by reducing the permeability of the BAL membrane.

UR - http://www.scopus.com/inward/record.url?scp=0242491821&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242491821&partnerID=8YFLogxK

U2 - 10.1097/01.TP.0000080067.79190.3C

DO - 10.1097/01.TP.0000080067.79190.3C

M3 - Article

C2 - 14627907

AN - SCOPUS:0242491821

VL - 76

SP - 1299

EP - 1305

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 9

ER -